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1. Introduction
Pregnancy rates achieved by intercourse in normal human couples are 20-25% per month, 75%
by six months, and 90% by one year [1]. However, 15% of couples of unknown fertility status
are unable to conceive a baby after one year of intercourse without contraception. For 30% of
these couples, their infertility can be attributed to a male factor alone; in an additional 20%,
failure to conceive is explained by the presence of both male and female factors [2,3,4]. Among
couples known to be infertile, a male factor is involved in 50% of the cases. The most common
causes of male infertility include abnormal sperm production or function, impaired delivery
of sperm, and overexposure to certain gonadotoxins in the environment. The pathogenesis of
male infertility can be attributed to a disorder of germ-cell proliferation and differentiation or
to somatic cell dysfunction [5].
The induction of spermatogenesis depends on the complementary actions of FSH and
testosterone. FSH establishes the requisite Sertoli cell population. In the prepubertal primate,
FSH alone can induce proliferation of Sertoli cells and spermatogonia, but this does not result
in qualitatively and quantitatively normal spermatogenesis unless testosterone is simultane‐
ously present [6] [7]. Testosterone affects the functional completion of meiosis and post-meiotic
sperm differentiation and maturation. LH stimulates Leydig cells to produce testosterone.
Although FSH appears to play a more dominant role in the maintenance of primate sperma‐
togenesis than in its initiation, normal spermatogenesis is best maintained by the combined
effects of FSH and LH [6].
The most severe form of male infertility is nonobstructive azoospermia, which is typically
characterized by small-volume testes and elevated FSH. Patients with this disorder cannot
© 2013 Kobayashi et al.; licensee InTech. This is an open access article distributed under the terms of the
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produce biological children. Although microdissection testicular sperm extraction (micro-
TESE) is used to treat patients with nonobstructive azoospermia [8], this technique does not
have a good success rate. Therefore, new approaches are needed to develop treatments for
male infertility.
Stem cells have the potential to differentiate into a variety of functional cell types in the body,
and their discovery has given rise to the fields of regenerative medicine and cloning. Stem cells
are regulated by the particular microenvironment in which they reside; these microenviron‐
ments are referred to as niches. Male germline stem cells can continuously produce sperm
throughout adulthood, and investigators have sought to develop methods using stem cells to
improve or restore fertility.
Embryonic stem cells (ESCs) have the potential to differentiate into nearly every cell type in
the body. As the cells differentiate, they lose the ability to develop into different tissues. In
contrast, specific tissues (gastrointestinal, integumentary, spermatogenic, and hematopoietic
systems) maintain their regenerative capacity in vivo, and in fact, stem cells have been
functionally identified in a wide range of adult tissues. These adult stem cells are believed to
hold great promise for tissue generation in clinical settings. Here, we provide a summary of
the therapeutic potential of stem cells for the rejuvenation of fertility in infertile males. Our
hope is that future research will provide a range of options for the preservation of male fertility
or the reversal of infertility.
2. Differentiation and characterization of human primordial germ cells
Human primordial germ cells (PGCs) can be isolated from tissues and their identity confirmed
by observing their migratory activity in vitro [9]. Cultured human PGCs become human
embryonic germ cells (hEGCs) in vitro, in the presence of feeder cells, leukemia inhibitory
factor (LIF), and basic fibroblast growth factor (bFGF) [10]. hEGCs express alkaline phospha‐
tase (AP), OCT4, SOX2, NANOG, stage specific embryonic antigen (SSEA)-3, SSEA-4,
TRA-1-60, and TRA-1-81, which are pluripotent stem cell markers. In vivo, human PGCs do
not express FGF4, SOX2 [11] [12], TRA-1-60, or TRA-1-81 [13] [14], which are expressed by
hESCs or hEGCs in vitro. The molecular signature of human PGCs in vivo can be characterized
as C-KIT+, SOX2-, TRA1-60-, TRA1-81-, and FGF4-, in contrast with human pluripotent stem
cell lines in vitro. (This information is summarized in Table 1.) However, the full complement
of genes that are expressed specifically in human PGCs and their functions remain unclear.
3. Spermatogonial stem cells
Spermatogenesis is a complex and tightly regulated process in which a small pool of germ-
line stem cells ultimately gives rise to spermatozoa [15]. These stem cells, called spermatogo‐
nial stem cells (SSCs) are found in the basal compartment of the seminiferous epithelium,
where they adhere to the basement membrane. SSC self-renewal ensures the maintenance of
Pluripotent Stem Cells118
the stem cell pool, while their differentiation generates a large number of germ cells. Therefore,
a balance between SSC self-renewal and differentiation in the adult testis is essential to
maintain normal spermatogenesis and fertility throughout life. SSCs need to reside in a unique
environment, or niche, that provides the factors necessary for their survival and potency. In
mice, Sertoli cells in the testis are a crucial component of the spermatogonial stem cell niche.
They produce glial cell line-derived neurotrophic factor (GDNF), a distant member of the
TGFβ family, which controls SSC self-renewal [16]. Several groups have reported that adding
GDNF to freshly isolated germ cells in culture results in the proliferation of SSCs [17,18]. Other
factors within the niche influence the fate of SSCs. One example is colony-stimulating factor 1
(CSF1), which is produced by Leydig cells and some peritubular myoid cells [19], and plays a
role in SSC self-renewal (Figure 1).
The existence of SSCs was postulated almost 40 years ago on the basis of morphological studies
[20] [21] [22] and observations of toxin-induced spermatogenic damage. The early studies of
Clermont [23] [24] on human spermatogenesis revealed two types of spermatogonia, the
Adark and Apale spermatogonia, which were differentiated by the staining pattern of their
nucleus. Both cell types are generally considered stem cells [24,25]. Adark spermatogonia
function as reverse stem cells that rarely divide, but can be triggered to self-renew in the case
of injury or disease, while Apale spermatogonia are self-renewing stem cells [23,24,25,26]; they
also divide into B spermatogonia, which further divide into spermatocytes [24].
In the last decade, molecular markers that can be used to identify and characterize human SSCs
have been sought. A recent study reported that the expression of surface marker G protein
coupled receptor 125 (GPR125) can be used in the isolation, characterization, and culture of
putative human SSCs [27]. GPR125-positive spermatogonia are very rare, possibly limited to
Adark spermatogonia or a sub-population of Apale spermatogonia. Human SSCs are also positive
Table 1. Markers of human pluripotent stem cells and germ cells.
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for some markers identified in mouse SSCs and other undifferentiated spermatogonia,
including GFRA1, UCHL1 (PGP9.5), ZBTB16 (PLZF), and THY1 (CD90) [27,28]. We also have
obtained evidence that THY1 is a potential surface marker for human SSCs [29].
Brinster and colleagues proved the existence of mouse SSCs by using unique approaches [30,
31]. These investigators transplanted cells obtained as testicular homogenates expressing the
LacZ gene into the seminiferous tubules of otherwise sterile mice with a Sertoli-cell-only
pathology. After three months, the transplanted spermatogonial stem cells had engrafted and
colonized the seminiferous tubules. Spermatogenesis was restored.
The clinical implications of this work are enormous. The findings suggest that the isolation,
enrichment, and cryopreservation of spermatogonial stem cells prior to chemotherapy or
radiation therapy, with later autologous transplantation, may offer the potential for the
subsequent restoration of fertility. The development of this technique will be especially
important for survivors of childhood cancer. Adult patients can also bank sperm for cryopre‐
Figure 1. Diagram of the spermatogonial stem cell (SSC) niche showing that extrinsic factors drive SSC maintenance
and self-renewal. SSCs and Sertoli cells are attached to the basement membrane. Sertoli cells produce glial cell line-
derived neurotrophic factor (GDNF) and basic fibroblast growth factor (bFGF). Leydig cells and peritubular cells pro‐
duce colony-stimulating factor-1 (CSF-1).
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servation. However, most couples would prefer a naturally conceived child. Work has
progressed in many laboratories to partially enrich the spermatogonial stem cells of species
ranging from mice to primates. Today, many urologists bank a testicular biopsy from patients
about to undergo chemotherapy, with the expectation that technology will advance rapidly
over the next 10 years and allow transplantation in the future.
4. Pluripotency of human testis–derived ESC–like cells
Previous studies have demonstrated that neonatal and adult germline stem cells (GSCs) can
be self-reprogrammed into ESC-like cells, called germline-derived pluripotent stem cells
[32,33,34,35]. In addition, Conrad et al. [36] reported that pluripotent cells can be derived from
human testis, which those authors called human adult GSCs (haGSCs). Other research groups
subsequently claimed that ESC-like cells could be obtained from cultures of human testicular
cells [37,38,39]. Conrad and colleagues compared the global gene expression profile of hESCs
and haGSCs, and concluded that the populations presented a similar gene expression profile,
and thus, that the haGSCs were pluripotent. However, Ko et al. claimed that the gene expres‐
sion profile of haGSCs differed substantially from the pluripotent profile of hESCs, determined
by a number of laboratories [40]. For example, the haGSCs did not express NANOG, and had
low OCT4 and SOX2 levels, but showed high levels of the fibroblast markers SNA12 and
ACTA2 [40]. Ko and colleagues therefore suggested that the haGSCs originated from fibroblast
cells, rather than from pluripotent tissue. They concluded that haGSCs were very similar to a
human testicular fibroblast cell line (hTFCs) [40]. Conrad and colleagues argued that micro‐
array data sets cannot be compared unless they are processed in parallel in the same experi‐
ment, suggesting that the similarity between haGSCs and hTFCs was inconclusive. However,
studies on microarray results generated by different laboratories [41,42,43] have shown that
findings from microarray analyses are comparable across multiple laboratories [44], particu‐
larly when a common platform and set of procedures are used. These findings justify the utility
of microarray repositories, such as the GEO database [45], not only as data warehouses but
also as resources for comparative and combinatory analyses of microarray data from different
laboratories. In conclusion, the global gene expression analysis of haGSCs demonstrated that
these cells resembled fibroblast hTFCs more than pluripotent hESCs.
5. Induced pluripotent stem (iPS) cells
The year 2006 saw the first description of mouse induced pluripotent stem cells (miPSCs),
which were generated by the retrovirus-mediated transduction of four transcription factors
(OCT3/4, SOX2, KLF4, and C-MYC) into mouse fibroblasts [46]. Human somatic cells can be
reprogrammed to become human iPSCs via the introduction of a small set of genes, either
those encoding OCT3/4, SOX2 and KLF4, with or without the addition of C-MYC, or an
alternate combination of OCT3/4, SOX2, LIN28, and NANOG [47,48,49,50,51,52,53,54,55].
Human iPSCs (hiPSCs) have remarkable similarity to hESCs in terms of their morphology, in
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vitro characteristics, proliferation rate, gene expression, and ability to differentiate into
mesoderm, endoderm, and ectoderm, both in vitro and in vivo, in teratoma assays [56,57].
In our laboratory, we induced iPS cells from adult human testicular tissue by introducing four
transcription factors, OCT4, SOX2, KLF4, and C-MYC, using lentiviral vectors [58]. We also
generated ES-like cells from 293FT cells by using OCT4, SOX2, NANOG, and LIN28 [59].
Finally, we generated iPS cells derived from the human testicular tissue of individuals with
Klinefelter syndrome (KS, also called 47, XXY) [60].
6. Germline differentiation from ESCs and iPSCs in humans
Recent studies indicate that mouse [61,62,63,64,65] and human [66,67] [50,68,69,70,71] ESCs
can differentiate in vitro into oocyte- or sperm-like cells. In particular, Clark et al. first reported
the spontaneous differentiation of germ cells in embryoid bodies derived from human ESCs
[66]. Male germline cells express specific RNA and protein markers, such as VASA. In 2009,
Park et al. demonstrated that PGC-like cells can be differentiated from human iPSCs [50].
Subsequent reports on male germline differentiation from stem cells have used one of three
approaches: (1) specific culture conditions, (2) manipulation of gene expression, and (3)
purification of germ cells.
Culture conditions supporting differentiation into germline cells. Bucay et al. observed that
as hESCs differentiate into putative germline cells, they also produce Sertoli-like support cells
[69]. In addition, co-cultures of hESCs and hiPSCs with human fetal gonadal stromal cells [50],
mouse Sertoli cells [72], or mouse embryonic fibroblasts [67] resulted in the increased efficiency
of germ cell-like differentiation. Co-culture systems are used to mimic a suitable microenvir‐
onment for the growing germ cells. For the differentiation of germline-like cells from hESCs
and hiPSCs, cytokines and other cell-signaling molecules are often added to the cultures. For
example, BMP4 and other BMPs are added to promote PGC-like differentiation from hESCs
and hiPSCs [73,74,75]. In addition, retinoic acid has been used to stimulate meiosis [75] [76].
Panula and colleagues reported the differentiation of fetal- and adult-derived iPSCs into germ
cells, and showed that ~5% of human iPSCs differentiated into PGCs following induction with
BMPs [77].
Manipulation of gene expression. By manipulating gene expression, researchers can regulate
the cell lineage decisions of differentiating pluripotent stem cells. Overexpression of DAZL
and VASA promotes PGC formation in differentiating human ESCs and iPSCs [78]. In addition,
Kee and colleagues (2009) reported that hESCs differentiate into germline cells that initiate
meiosis and progress to form haploid germ cells. These authors indicated that the overexpres‐
sion of members of the DAZ gene family, DAZ, DAZL, and BOULE, promoted the progression
of PGCs to meiosis and the production of haploid cells, a process that is unique to germ cell
development [71].
Purification of germline cells. The isolation and purification of germline cells from stem cell
cultures (ESCs and iPSCs) can be performed efficiently when specific antibodies for germ cell
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surface markers are available. To purify PGC-like cells from differentiating human ESCs and
iPSCs, cell sorting with specific antibodies for SSEA1 [68], SSEA1 and C-KIT [50] [79], or CXCR4
[69] has been effective. In particular, Eguizabal et al. (2011) published a straightforward
protocol for germline cell purification that requires only three steps. First, human iPSCs and
hESCs are allowed to differentiate for 3 weeks in a monolayer, in the absence of growth
cytokines. Second, the cells are cultured for 3 weeks in the presence of retinoic acid. Finally,
after these 6 weeks of differentiation, the cells are sorted for a specific combination of surface
markers (CD49f++, CD9+, CD90-, and SSEA4-), and the isolated fraction is cultured in the
presence of LIF, bFGF, Forskolin, and CYP26 inhibitor for 4 more weeks [76].
7. Germline differentiation from porcine iPSCs, non–human iPSCs
Despite their undoubted promise as sources of cells for tissue transplants, many roadblocks
remain against using human ESCs clinically. Particularly troubling is the lack of tests for the
efficacy of such therapies and the safety of transferring these cells in animals whose anatomy
and physiology resemble those of humans better than mouse models do [80] [81] [82] [83] [84].
The pig is a potentially useful model in this regard, because of its similarities to humans in
organ size, immunology, and whole animal physiology [85] [86] [87]. It was reported that
porcine somatic cells can be reprogrammed to form piPSCs [88]. However, no reports on
germline development from piPSCs have been published to date.
8. Conclusions
Research on stem cells has shown remarkable progress over the past 5 years. In particular, the
development of human iPSCs has opened new avenues into the generation of an in vitro disease
model of male infertility. However, improvements are still needed before stem cells can be
used clinically. For the treatment and diagnosis of male infertility, future advances may enable
spermatids to be differentiated from germline stem cells or iPS cells. In addition, by examining
patient-specific iPSCs that are defective in their ability to generate germ cells and comparing
their differentiation capacity with that of normal human ESCs and iPSCs, researchers can hope
to uncover the nature of male infertility and to design new methods to reverse it.
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